BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15721448)

  • 1. Plasmacytoid dendritic cells are present in cervical carcinoma and become activated by human papillomavirus type 16 virus-like particles.
    Bontkes HJ; Ruizendaal JJ; Kramer D; Meijer CJ; Hooijberg E
    Gynecol Oncol; 2005 Mar; 96(3):897-901. PubMed ID: 15721448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells.
    Lenz P; Lowy DR; Schiller JT
    Eur J Immunol; 2005 May; 35(5):1548-56. PubMed ID: 15832296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous papillomavirus virus-like particles and human papillomavirus virus-like particle immune complexes activate human Langerhans cells.
    Fausch SC; Da Silva DM; Kast WM
    Vaccine; 2005 Feb; 23(14):1720-9. PubMed ID: 15705478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells--at the front-line of pathogen attack.
    McCullough KC; Ruggli N; Summerfield A
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):7-15. PubMed ID: 19036457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.
    Sheu BC; Chang WC; Lin HH; Chow SN; Huang SC
    J Obstet Gynaecol Res; 2007 Apr; 33(2):103-13. PubMed ID: 17441881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells.
    Yan M; Peng J; Jabbar IA; Liu X; Filgueira L; Frazer IH; Thomas R
    Virology; 2004 Jul; 324(2):297-310. PubMed ID: 15207617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for the prevention of cervical cancer by human papillomavirus vaccination.
    Williamson AL; Passmore JA; Rybicki EP
    Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):531-44. PubMed ID: 16150392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus overrides the propensity of human CD40L-activated plasmacytoid dendritic cells to produce Th2 mediators through synergistic induction of IFN-{gamma} and Th1 chemokine production.
    Bendriss-Vermare N; Burg S; Kanzler H; Chaperot L; Duhen T; de Bouteiller O; D'agostini M; Bridon JM; Durand I; Sederstrom JM; Chen W; Plumas J; Jacob MC; Liu YJ; Garrone P; Trinchieri G; Caux C; Brière F
    J Leukoc Biol; 2005 Oct; 78(4):954-66. PubMed ID: 16081597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S; Alain S; Denis F
    Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune evasion in human papillomavirus-associated cervical cancer.
    Tindle RW
    Nat Rev Cancer; 2002 Jan; 2(1):59-65. PubMed ID: 11902586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro-generated viral double-stranded RNA in contrast to polyinosinic:polycytidylic acid induces interferon-alpha in human plasmacytoid dendritic cells.
    Löseke S; Grage-Griebenow E; Heine H; Wagner A; Akira S; Bauer S; Bufe A
    Scand J Immunol; 2006 Apr; 63(4):264-74. PubMed ID: 16623926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine.
    García-Piñeres AJ; Hildesheim A; Trivett M; Williams M; Wu L; Kewalramani VN; Pinto LA
    Eur J Immunol; 2006 Feb; 36(2):437-45. PubMed ID: 16385626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylactic and therapeutic vaccination against human papillomavirus].
    Brun JL; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2007 Nov; 36(7):631-41. PubMed ID: 17822860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoepithelioma-like carcinoma of the uterine cervix: absence of Epstein-Barr virus, but presence of a multiple human papillomavirus infection.
    Bais AG; Kooi S; Teune TM; Ewing PC; Ansink AC
    Gynecol Oncol; 2005 May; 97(2):716-8. PubMed ID: 15863191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-level HIV infection of plasmacytoid dendritic cells: onset of cytopathic effects and cell death after PDC maturation.
    Schmidt B; Scott I; Whitmore RG; Foster H; Fujimura S; Schmitz J; Levy JA
    Virology; 2004 Nov; 329(2):280-8. PubMed ID: 15518808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus vaccines.
    Stanley MA
    Rev Med Virol; 2006; 16(3):139-49. PubMed ID: 16710836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG-derived Fc down-regulates virus-induced plasmacytoid dendritic cell (pDC) IFNalpha production.
    Green DS; Lum T; Green JA
    Cytokine; 2004 Jun; 26(5):209-16. PubMed ID: 15157898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV: from infection to cancer.
    Stanley MA; Pett MR; Coleman N
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1456-60. PubMed ID: 18031245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of IL-10 in immune suppression in cervical cancer.
    Bhairavabhotla RK; Verm V; Tongaonkar H; Shastri S; Dinshaw K; Chiplunkar S
    Indian J Biochem Biophys; 2007 Oct; 44(5):350-6. PubMed ID: 18341210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.
    Lövgren T; Eloranta ML; Kastner B; Wahren-Herlenius M; Alm GV; Rönnblom L
    Arthritis Rheum; 2006 Jun; 54(6):1917-27. PubMed ID: 16729300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.